← Leaderboards
Carolina Schinke
Univ Of Arkansas For Med Scis
$951,665
Attributed
$951,665
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $273.6K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$951,665 · 1
By mechanism
P20$951,665 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Elias J Anaissie$666,605
- Ellis Benjamin$108,831
Others in their field
Other Emerging Leaders on “Clinical Research”
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lynn Briscoe · Leidos Biomedical Research, Inc.$319,807,684
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
Clinical ResearchConditioningAcute Myelocytic LeukemiaAcute LeukemiaAutologousAdverse OutcomeAlkylating AgentsBiobankBlood SpecimenArkansasBone CellBone MarrowBone Marrow BiopsyAutologous Stem Cell TransplantationCancer TherapyCell AgingCell InjuryCell PhysiologyCellsCenters Of Research ExcellenceCessation Of LifeChemotherapyCisplatinCore Facility
Grant awards (4)
Therapy-induced Damage to the Host Bone Marrow as a Promoter of Treatment Resistance in Multiple Myeloma$136,800
P20 · FY2023 · GM · contact PI
Therapy-induced Damage to the Host Bone Marrow as a Promoter of Treatment Resistance in Multiple Myeloma$267,665
P20 · FY2022 · GM · contact PI
Therapy-induced Damage to the Host Bone Marrow as a Promoter of Treatment Resistance in Multiple Myeloma$273,600
P20 · FY2021 · GM · contact PI
Therapy-induced Damage to the Host Bone Marrow as a Promoter of Treatment Resistance in Multiple Myeloma$273,600
P20 · FY2020 · GM · contact PI